Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
177Lu-PSMA-617 beter dan cabazitaxel in fase II-studie
apr 2021 | Uro-oncologie